Fluoxetine versus phenelzine in atypical depression

Biological Psychiatry - Tập 40 - Trang 1017-1020 - 1996
Atul C. Pande1, Martin Birkett2, Suzanne Fechner-Bates1, Roger F. Haskett1, John F. Greden1
1Depression Program, University of Michigan Department of Psychiatry, Ann Arbor, Michigan, USA
2Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, U.K.

Tài liệu tham khảo

Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Pande, 1993, Adverse events and treatment discontinuations in fluoxetine clinical trials, Int Clin Psychopharmacol, 8, 267, 10.1097/00004850-199300840-00010 Quitkin, 1993, Columbia atypical depression: A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo, Br J Psychiatry, 163, 30, 10.1192/S0007125000292465 Reimherr, 1984, Characteristics of responders to fluoxetine, Psychopharmacol Bull, 20, 70 Stewart, 1993, Atypical Depression, 215 Thase, 1992, Treatment of imipramine resistant recurrent depression: IV. A double-blind, cross-over study of tranylcypromine in anergic bipolar depression, Am J Psychiatry, 149, 195, 10.1176/ajp.149.2.195